LKFTLakefront Biotherapeutics NV
$29.74-13% 1Y
$29.74
$26.0752 weeks$37.62
What is the market doing?
Mixed
2 neutral, 1 without dataNo clear lean: rangebound and moderately shorted.
TrendRangeboundderived · Oct 9, 2026
Rangebound, no clear trend. Price is −2% vs its 200-day average.
Short interest5.2% of sharesFINRA · Sep 15, 2026
Moderately shorted, settled Sep 15, 2026, more than a week of normal trading to cover, a crowded exit.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How LKFT is trading
Lakefront Biotherapeutics NV is −13% over the past year while the S&P 500 is +18%: 31 points behind the market.
−13%
1-year return · S&P 500 +18%
- vs 200-day average
- −1.6%
vs 200-day average · below trend, but not far
- RSI (14)
- 51
RSI (14) · neutral
- Below its 52-week high
- 21%
Below its 52-week high
Details›
- Last close2026-10-09
- $29.74
- 1 monthS&P 500 +2.7%
- +11%
- 1 yearS&P 500 +18%
- −13%
- 5 yearsS&P 500 +88%
- −48%
- vs 50-day average$28.48
- +4.4%
- 52-week high
- $37.62
- 52-week low
- $26.07
- Annualised volatility
- 32%
| Year | Return |
|---|---|
| 2026 (year to date) | −9.1% |
| 2025 | +19% |
| 2024 | −32% |
| 2023 | −8.4% |
| 2022 | −19% |
| 2021 | −44% |
| 2020 | −52% |
| 2019 | +125% |
| 2018 | −2.2% |
| 2017 | +46% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 7 of 10 | +5.4% |
| Feb | 10 | 2 of 10 | −4.5% |
| Mar | 10 | 3 of 10 | −0.16% |
| Apr | 10 | 5 of 10 | −1.6% |
| May | 10 | 4 of 10 | +0.48% |
| Jun | 10 | 3 of 10 | −2.7% |
| Jul | 11 | 6 of 11 | +5.1% |
| Aug | 11 | 3 of 11 | −2.9% |
| Sep | 11 | 6 of 11 | +1.5% |
| Oct | 11 | 4 of 11 | −2.6% |
| Nov | 10 | 4 of 10 | −0.82% |
| Dec | 10 | 7 of 10 | +3.0% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.